September 26, 2019
Mylan EPD said on September 24 that it has submitted a clinical trial application to the Pharmaceuticals and Medical Devices Agency (PMDA), aiming to start a PIII trial for A0003 (development code), an ophthalmic solution for the treatment of cystinosis,...read more